Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

Alignment healthcare president sells $164k in stock

Published 06/14/2024, 05:52 PM
ALHC
-

In a recent transaction on June 12, Dawn Christine Maroney, President of Markets at Alignment Healthcare, Inc. (NASDAQ:ALHC), sold 20,000 shares of company stock. The total value of the stock sold amounted to approximately $164,200, with shares being sold at a weighted-average price of $8.21.

The sale was conducted in multiple transactions at prices ranging from $8.06 to $8.40 per share. After the sale, Maroney continues to own 1,956,097 shares of Alignment Healthcare. The transactions were disclosed in a Form 4 filing with the Securities and Exchange Commission, dated June 14.

Investors often monitor insider sales as they may provide insights into a company's financial health or an executive's view of the company's future prospects. However, insider transactions can be subject to various personal financial considerations and should not be taken as the sole indicator of a company's performance or outlook.

Alignment Healthcare, specializing in hospital and medical service plans, continues to be represented by its executives in the market, with transactions such as these being part of the regular financial activities disclosed to the public.

In other recent news, Alignment Healthcare has reported significant developments. The company has amended its corporate charter, a move approved by stockholders, which limits the liability of certain officers. This amendment aligns with Delaware state law and became effective upon its filing. Stockholders also voted on several other proposals, including the election of Class III directors and the ratification of the company's independent auditor, Deloitte & Touche LLP.

BofA Securities upgraded Alignment Healthcare's stock from Neutral to Buy, attributing this change to improved visibility into the company's margin progression. In addition, Piper Sandler upgraded the company's stock from Neutral to Overweight, following robust first-quarter results for 2024 and a revised full-year 2024 guidance.

The company reported a 50% increase in health plan membership and a 43% rise in total revenue in the first quarter of 2024. Despite being negative, the company's adjusted EBITDA was better than anticipated. Looking ahead, Alignment Healthcare is aiming for at least a 20% increase in health plan membership and margin expansion in 2025. These are recent developments and reflect the company's commitment to growth and transparency with its stockholders.

InvestingPro Insights

Following the insider sale by Dawn Christine Maroney, President of Markets at Alignment Healthcare, Inc. (NASDAQ:ALHC), investors might be keen to understand the broader financial context of the company. According to real-time data from InvestingPro, Alignment Healthcare has a market capitalization of approximately $1.58 billion. The company's performance has been marked by significant revenue growth, with a 31.76% increase over the last twelve months as of Q1 2024, and an even more impressive quarterly surge of 43.14% in Q1 2024.

Despite these growth figures, InvestingPro Tips suggest caution. Analysts have revised their earnings downwards for the upcoming period, and the Relative Strength Index (RSI) indicates that the stock is currently in overbought territory. Additionally, the company's gross profit margins appear weak at 10.61%, which could be a concern for investors looking for sustainable profitability. It's worth noting that analysts do not anticipate the company will be profitable this year, and the company has not been profitable over the last twelve months.

On the positive side, Alignment Healthcare has experienced strong returns, with an 18.86% increase over the past month and a significant 72.61% gain over the last three months. However, the company trades at a high Price / Book multiple of 12.15, which could suggest that the stock is valued richly relative to its book value.

For investors seeking a more in-depth analysis, there are additional InvestingPro Tips available for Alignment Healthcare. With these insights, investors can make more informed decisions about their investment strategies. To explore further, visit https://www.investing.com/pro/ALHC and consider using the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. There are 10 additional InvestingPro Tips listed on the site that could provide valuable guidance for those interested in ALHC's stock.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.